{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:16:27Z","timestamp":1768284987258,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012700","name":"Japan Health Foundation.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD) is an X-linked recessive myopathy caused by dystrophin mutations. Although respiratory management has improved the prognosis of patients with DMD, inevitable progressive cardiomyopathy is a current leading cause of premature death. Recently, we showed that a medium-chain triglyceride containing ketogenic diet (MCTKD) improves skeletal muscle function and pathology in a CRISPR\/Cas9 gene-edited rat model with DMD. In this study, we sought to clarify whether MCTKD also improves the cardiomyopathy in these rats. DMD rats were fed either the MCTKD or normal diet (ND) from ages of 3\u00a0weeks to 9\u00a0months old. Compared with the ND-fed rats, MCTKD-fed rats showed significantly prolonged QRS duration, decreased left ventricular fractional shortening, an increased heart weight\/body weight ratio, and progression of cardiac fibrosis. In contrast to our previous study which found that MCTKD improved skeletal myopathy, the current study showed unexpected exacerbation of the cardiomyopathy. Further studies are needed to explore the underlying mechanisms for these differences and to explore modified dietary options that improve skeletal and cardiac muscles simultaneously.<\/jats:p>","DOI":"10.1038\/s41598-022-15934-9","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T10:02:33Z","timestamp":1657274553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A medium-chain triglyceride containing ketogenic diet exacerbates cardiomyopathy in a CRISPR\/Cas9 gene-edited rat model with Duchenne muscular dystrophy"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuri","family":"Fujikura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haotong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Daimon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutaka","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"15934_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.RES.0000126574.61061.25","volume":"94","author":"KA Lapidos","year":"2004","unstructured":"Lapidos, K. A., Kakkar, R. & Mcnally, E. M. The dystrophin glycoprotein complex. Circ. Res. 94, 1023\u20131031 (2004).","journal-title":"Circ. Res."},{"key":"15934_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","volume":"15","author":"IEC Verhaart","year":"2019","unstructured":"Verhaart, I. E. C. & Aartsma-Rus, A. Therapeutic developments for Duchenne muscular dystrophy. Nat. Rev. Neurol. 15, 373\u2013386 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"15934_CR3","doi-asserted-by":"crossref","unstructured":"Matthews, E., Brassington, R., Kuntzer, T., Jichi, F. & Manzur, A.Y. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 5, CD003725 (2016).","DOI":"10.1002\/14651858.CD003725.pub4"},{"key":"15934_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"S Yusuf","year":"1991","unstructured":"Yusuf, S. et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325, 293\u2013302 (1991).","journal-title":"N. Engl. J. Med."},{"key":"15934_CR5","doi-asserted-by":"crossref","unstructured":"Bourke, J.P. et al. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): A protocol study. BMJ Open 8, e022572 (2018).","DOI":"10.1136\/bmjopen-2018-022572"},{"key":"15934_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","unstructured":"CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 353, 9\u201313 (1999).","journal-title":"Lancet"},{"key":"15934_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(97)80008-6","volume":"349","author":"S MacMahon","year":"1997","unstructured":"MacMahon, S. et al. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 349, 375\u2013380 (1997).","journal-title":"Lancet"},{"key":"15934_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.rehab.2013.06.002","volume":"56","author":"P Kieny","year":"2013","unstructured":"Kieny, P. et al. Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011. Ann. Phys. Rehabil. Med. 56, 443\u2013454 (2013).","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"15934_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1253\/circj.CJ-18-1060","volume":"83","author":"O Seguchi","year":"2019","unstructured":"Seguchi, O. et al. Heart transplantation ameliorates ambulation capacity in patients with muscular dystrophy\u2014an analysis of 9 cases. Circ. J. 83, 684\u2013686 (2019).","journal-title":"Circ. J."},{"key":"15934_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","volume":"90","author":"RM Grady","year":"1997","unstructured":"Grady, R. M. et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: A model for Duchenne muscular dystrophy. Cell 90, 729\u2013738 (1997).","journal-title":"Cell"},{"key":"15934_CR11","doi-asserted-by":"crossref","unstructured":"Nakamura, K. et al. Generation of muscular dystrophy model rats with a CRISPR\/Cas system. Sci. Rep. 4, 5635 (2014).","DOI":"10.1038\/srep05635"},{"key":"15934_CR12","unstructured":"Sugihara, H. et al. Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy. Sci. Rep. 4, 16385 (2014)."},{"key":"15934_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1536\/ihj.20-372","volume":"61","author":"H Sugihara","year":"2020","unstructured":"Sugihara, H. et al. Age-dependent echocardiographic and pathologic findings in a rat model with duchenne muscular dystrophy generated by CRISPR\/Cas9 genome editing. Int. Heart J. 61, 1279\u20131284 (2020).","journal-title":"Int. Heart J."},{"key":"15934_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1293\/tox.2020-0018","volume":"33","author":"M Miyamoto","year":"2020","unstructured":"Miyamoto, M. et al. Cardiac lesions in Duchenne muscular dystrophy model rats with out-of-frame Dmd gene mutation mediated by CRISPR\/Cas9 system. J. Toxicol. Pathol. 33, 227\u2013236 (2020).","journal-title":"J. Toxicol. Pathol."},{"key":"15934_CR15","doi-asserted-by":"publisher","first-page":"2630565","DOI":"10.1155\/2018\/2630565","volume":"2018","author":"DC Harvey","year":"2018","unstructured":"Harvey, D. C., Schofield, C. J., Williden, G. M. & McQuillan, J. A. The effect of medium chain triglycerides on time to nutritional ketosis and symptoms of keto-induction in healthy adults: A randomised controlled clinical trial. J. Nutr. Metab. 2018, 2630565 (2018).","journal-title":"J. Nutr. Metab."},{"key":"15934_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","volume":"7","author":"EG Neal","year":"2008","unstructured":"Neal, E. G. et al. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurol. 7, 500\u2013506 (2008).","journal-title":"Lancet Neurol."},{"key":"15934_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin, K. et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. 17, 84\u201393 (2018).","journal-title":"Lancet Neurol."},{"key":"15934_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fphar.2012.00059","volume":"3","author":"CE Stafstrom","year":"2012","unstructured":"Stafstrom, C. E. & Rho, J. M. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front. Pharmacol. 3, 59 (2012).","journal-title":"Front. Pharmacol."},{"key":"15934_CR19","doi-asserted-by":"crossref","unstructured":"Nakao, R., Abe, T., Yamamoto, S. & Oishi, K. Ketogenic diet induces skeletal muscle atrophy via reducing muscle protein synthesis and possibly activating proteolysis in mice. Sci. Rep. 9, 19652 (2019).","DOI":"10.1038\/s41598-019-56166-8"},{"key":"15934_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1123\/ijsnem.2015-0070","volume":"26","author":"GM Tinsley","year":"2016","unstructured":"Tinsley, G. M. & Willoughby, D. S. Fat-Free mass changes during ketogenic diets and the potential role of resistance training. Int. J. Sport Nutr. Exerc. Metab. 26, 78\u201392 (2016).","journal-title":"Int. J. Sport Nutr. Exerc. Metab."},{"key":"15934_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/WNL.21.11.1097","volume":"21","author":"PR Huttenlocher","year":"1971","unstructured":"Huttenlocher, P. R., Wilbourn, A. J. & Signore, J. M. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 21, 1097\u20131103 (1971).","journal-title":"Neurology"},{"key":"15934_CR22","doi-asserted-by":"crossref","unstructured":"Fujikura, Y., Sugihara, H., Hatakeyama, M., Oishi, K. & Yamanouchi, K. Ketogenic diet with medium-chain triglycerides restores skeletal muscle function and pathology in a rat model of Duchenne muscular dystrophy. Faseb J. 35, e21861 (2021).","DOI":"10.1096\/fj.202100629R"},{"key":"15934_CR23","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1093\/cvr\/cvaa298","volume":"117","author":"M Nakamura","year":"2020","unstructured":"Nakamura, M. et al. Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure. Cardiovasc. Res. 117, 2365\u20132376 (2020).","journal-title":"Cardiovasc. Res."},{"key":"15934_CR24","doi-asserted-by":"publisher","first-page":"111058","DOI":"10.1016\/j.exger.2020.111058","volume":"140","author":"Y Yu","year":"2020","unstructured":"Yu, Y., Wang, F., Wang, J., Zhang, D. & Zhao, X. Ketogenic diet attenuates aging-associated myocardial remodeling and dysfunction in mice. Exp. Gerontol. 140, 111058 (2020).","journal-title":"Exp. Gerontol."},{"key":"15934_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/01.HYP.0000248430.26229.0f","volume":"48","author":"IC Okere","year":"2006","unstructured":"Okere, I. C. et al. Low carbohydrate\/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension 48, 1116\u20131123 (2006).","journal-title":"Hypertension"},{"key":"15934_CR26","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/HJH.0b013e3283007dda","volume":"26","author":"N Sharma","year":"2008","unstructured":"Sharma, N. et al. High-sugar diets increase cardiac dysfunction and mortality in hypertension compared to low-carbohydrate or high-starch diets. J. Hypertens. 26, 1402\u20131410 (2008).","journal-title":"J. Hypertens."},{"key":"15934_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cardfail.2007.11.003","volume":"14","author":"MK Duda","year":"2008","unstructured":"Duda, M. K. et al. Low-carbohydrate\/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J. Card. Fail. 14, 327\u2013335 (2008).","journal-title":"J. Card. Fail."},{"key":"15934_CR28","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","volume":"139","author":"R Nielsen","year":"2019","unstructured":"Nielsen, R. et al. Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients. Circulation 139, 2129\u20132141 (2019).","journal-title":"Circulation"},{"key":"15934_CR29","doi-asserted-by":"crossref","unstructured":"Heydemann, A. Skeletal muscle metabolism in duchenne and becker muscular dystrophy-implications for therapies. Nutrients 10, 796 (2018).","DOI":"10.3390\/nu10060796"},{"key":"15934_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.yjmcc.2009.09.004","volume":"48","author":"Y Burelle","year":"2010","unstructured":"Burelle, Y. et al. Alterations in mitochondrial function as a harbinger of cardiomyopathy: Lessons from the dystrophic heart. J. Mol. Cell. Cardiol. 48, 310\u2013321 (2010).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"15934_CR31","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"12","author":"D Montaigne","year":"2021","unstructured":"Montaigne, D., Butruille, L. & Staels, B. PPAR control of metabolism and cardiovascular functions. Nat. Rev. Cardiol. 12, 809\u2013823 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"15934_CR32","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/life11070706","volume":"11","author":"J Morroni","year":"2021","unstructured":"Morroni, J. et al. Accelerating the Mdx heart histo-pathology through physical exercise. Life Basel 11, 706 (2021).","journal-title":"Life Basel"},{"key":"15934_CR33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ajpath.2013.01.020","volume":"182","author":"C Hourde","year":"2013","unstructured":"Hourde, C. et al. Voluntary physical activity protects from susceptibility to skeletal muscle contraction-induced injury but worsens heart function in mdx mice. Am. J. Pathol. 182, 1509\u20131518 (2013).","journal-title":"Am. J. Pathol."},{"key":"15934_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jacc.2011.01.072","volume":"58","author":"M Diegoli","year":"2011","unstructured":"Diegoli, M. et al. Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J. Am. Coll. Cardiol. 58, 925\u2013934 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"15934_CR35","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","volume":"161","author":"O Bergmann","year":"2015","unstructured":"Bergmann, O. et al. Dynamics of cell generation and turnover in the human heart. Cell 161, 1566\u20131575 (2015).","journal-title":"Cell"},{"key":"15934_CR36","doi-asserted-by":"publisher","first-page":"15553","DOI":"10.1038\/s41598-020-72686-0","volume":"10","author":"H Toko","year":"2020","unstructured":"Toko, H. et al. Omega-3 fatty acid prevents the development of heart failure by changing fatty acid composition in the heart. Sci. Rep. 10, 15553 (2020).","journal-title":"Sci. Rep."},{"key":"15934_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/00325481.2019.1607414","volume":"131","author":"JR Nelson","year":"2019","unstructured":"Nelson, J. R. & Raskin, S. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease. Postgrad. Med. 131, 268\u2013277 (2019).","journal-title":"Postgrad. Med."},{"key":"15934_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","volume":"56","author":"AP Simopoulos","year":"2002","unstructured":"Simopoulos, A. P. The importance of the ratio of omega-6\/omega-3 essential fatty acids. Biomed. Pharmacother. 56, 365\u2013379 (2002).","journal-title":"Biomed. Pharmacother."},{"key":"15934_CR39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.nut.2016.01.015","volume":"32","author":"AF Mauricio","year":"2016","unstructured":"Mauricio, A.F., Pereira, J.A., Santo Neto, H. & Marques, M. J. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice hearts at later stages of dystrophy. Nutrition  32,\u00a0855\u2013862 (2016).","journal-title":"Nutrition"},{"key":"15934_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/gerona\/gly139","volume":"74","author":"C de Lucia","year":"2019","unstructured":"C. de Lucia,\u00a0et al. Echocardiographic strain analysis for the early detection of left ventricular systolic\/diastolic dysfunction and dyssynchrony in a mouse model of physiological aging. J. Gerontol. A Biol. Sci. Med. Sci. 74, 455\u2013461 (2019).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"15934_CR41","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/CIRCRESAHA.110.239574","volume":"108","author":"M Bauer","year":"2011","unstructured":"Bauer, M. et al. Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ. Res. 108, 908\u2013916 (2011).","journal-title":"Circ. Res."},{"key":"15934_CR42","doi-asserted-by":"crossref","unstructured":"Du Sert, N. P. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 18, e3000410 (2020).","DOI":"10.1371\/journal.pbio.3000410"},{"key":"15934_CR43","unstructured":"American Veterinary Medical Association. AVMA guidelines on euthanasia, 2020 Edition, https:\/\/www.avma.org\/sites\/default\/files\/2020-02\/Guidelines-on-Euthanasia-2020.pdf (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15934-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15934-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15934-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:52:45Z","timestamp":1669359165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15934-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15934"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15934-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11580"}}